Concepts (315)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cognitive Dysfunction | 28 | 2025 | 737 | 4.470 |
Why?
|
| Healthy Lifestyle | 10 | 2024 | 36 | 3.320 |
Why?
|
| Cardiovascular Diseases | 16 | 2025 | 290 | 3.180 |
Why?
|
| Alzheimer Disease | 13 | 2025 | 1320 | 3.050 |
Why?
|
| Life Expectancy | 9 | 2022 | 21 | 2.330 |
Why?
|
| Diet, Mediterranean | 10 | 2024 | 63 | 2.220 |
Why?
|
| Obesity | 10 | 2020 | 289 | 2.210 |
Why?
|
| Aged | 62 | 2025 | 7448 | 1.890 |
Why?
|
| Body Mass Index | 13 | 2024 | 378 | 1.770 |
Why?
|
| Prospective Studies | 31 | 2025 | 1493 | 1.720 |
Why?
|
| Female | 66 | 2025 | 12958 | 1.640 |
Why?
|
| Risk Factors | 31 | 2025 | 1971 | 1.610 |
Why?
|
| Humans | 91 | 2025 | 22958 | 1.580 |
Why?
|
| Male | 58 | 2025 | 12466 | 1.560 |
Why?
|
| Apolipoprotein E4 | 8 | 2025 | 172 | 1.530 |
Why?
|
| Exercise | 13 | 2022 | 392 | 1.520 |
Why?
|
| Cognition | 15 | 2024 | 948 | 1.400 |
Why?
|
| Diabetes Mellitus, Type 2 | 7 | 2024 | 148 | 1.310 |
Why?
|
| Netherlands | 18 | 2024 | 25 | 1.280 |
Why?
|
| Aging | 11 | 2025 | 1102 | 1.210 |
Why?
|
| Cohort Studies | 21 | 2025 | 1417 | 1.150 |
Why?
|
| Independent Living | 6 | 2025 | 225 | 1.130 |
Why?
|
| Pediatric Obesity | 2 | 2018 | 42 | 1.070 |
Why?
|
| Mothers | 2 | 2018 | 160 | 0.980 |
Why?
|
| Stroke | 5 | 2023 | 241 | 0.970 |
Why?
|
| Neurodegenerative Diseases | 6 | 2025 | 96 | 0.910 |
Why?
|
| Aged, 80 and over | 23 | 2025 | 3728 | 0.880 |
Why?
|
| Chicago | 16 | 2025 | 813 | 0.880 |
Why?
|
| Waist Circumference | 4 | 2016 | 35 | 0.830 |
Why?
|
| Middle Aged | 30 | 2024 | 7911 | 0.820 |
Why?
|
| Dementia | 6 | 2024 | 388 | 0.810 |
Why?
|
| Vitamin D | 2 | 2022 | 27 | 0.790 |
Why?
|
| DNA Methylation | 6 | 2021 | 129 | 0.760 |
Why?
|
| Risk Assessment | 7 | 2024 | 548 | 0.730 |
Why?
|
| Longitudinal Studies | 10 | 2025 | 1046 | 0.720 |
Why?
|
| Overweight | 5 | 2021 | 66 | 0.700 |
Why?
|
| Blood Pressure | 3 | 2024 | 166 | 0.690 |
Why?
|
| Brain | 6 | 2024 | 1203 | 0.680 |
Why?
|
| Epigenomics | 4 | 2021 | 11 | 0.680 |
Why?
|
| Menopause | 5 | 2024 | 99 | 0.670 |
Why?
|
| United States | 9 | 2024 | 1765 | 0.650 |
Why?
|
| Dietary Approaches To Stop Hypertension | 4 | 2024 | 23 | 0.620 |
Why?
|
| Incidence | 9 | 2025 | 624 | 0.600 |
Why?
|
| Amino Acyl-tRNA Synthetases | 1 | 2018 | 1 | 0.580 |
Why?
|
| RNA-Binding Proteins | 1 | 2018 | 19 | 0.570 |
Why?
|
| Metabolic Syndrome | 2 | 2016 | 55 | 0.570 |
Why?
|
| Mortality | 2 | 2016 | 73 | 0.570 |
Why?
|
| Preconception Care | 1 | 2018 | 1 | 0.560 |
Why?
|
| Patient Compliance | 1 | 2018 | 146 | 0.520 |
Why?
|
| Lipids | 3 | 2025 | 45 | 0.520 |
Why?
|
| Biomarkers | 8 | 2025 | 476 | 0.520 |
Why?
|
| Proportional Hazards Models | 8 | 2024 | 274 | 0.500 |
Why?
|
| Life Style | 4 | 2022 | 159 | 0.500 |
Why?
|
| Neurofilament Proteins | 3 | 2025 | 16 | 0.500 |
Why?
|
| Obesity, Metabolically Benign | 1 | 2016 | 1 | 0.490 |
Why?
|
| tau Proteins | 3 | 2025 | 145 | 0.470 |
Why?
|
| Body Composition | 1 | 2016 | 66 | 0.470 |
Why?
|
| Anthropometry | 1 | 2015 | 29 | 0.460 |
Why?
|
| Alleles | 4 | 2024 | 165 | 0.460 |
Why?
|
| Somatotypes | 1 | 2014 | 2 | 0.450 |
Why?
|
| Follow-Up Studies | 5 | 2024 | 1412 | 0.440 |
Why?
|
| Genome-Wide Association Study | 5 | 2022 | 152 | 0.380 |
Why?
|
| Adult | 11 | 2024 | 6927 | 0.370 |
Why?
|
| Postmenopause | 3 | 2018 | 57 | 0.370 |
Why?
|
| Carotid Intima-Media Thickness | 3 | 2022 | 17 | 0.370 |
Why?
|
| Diet | 5 | 2024 | 178 | 0.360 |
Why?
|
| Risk Reduction Behavior | 4 | 2020 | 36 | 0.360 |
Why?
|
| Environmental Exposure | 2 | 2024 | 18 | 0.360 |
Why?
|
| Air Pollution | 2 | 2024 | 14 | 0.350 |
Why?
|
| Alcohol Drinking | 4 | 2020 | 65 | 0.350 |
Why?
|
| CpG Islands | 4 | 2021 | 43 | 0.350 |
Why?
|
| Atherosclerosis | 3 | 2022 | 44 | 0.340 |
Why?
|
| White Matter | 2 | 2022 | 107 | 0.340 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2021 | 262 | 0.320 |
Why?
|
| Surveys and Questionnaires | 5 | 2024 | 1020 | 0.310 |
Why?
|
| Apolipoproteins E | 4 | 2023 | 142 | 0.290 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 79 | 0.290 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 82 | 0.290 |
Why?
|
| Pandemics | 2 | 2020 | 206 | 0.290 |
Why?
|
| Population Surveillance | 2 | 2021 | 102 | 0.280 |
Why?
|
| Intermediate Filaments | 3 | 2023 | 19 | 0.280 |
Why?
|
| Coronary Disease | 2 | 2018 | 49 | 0.280 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2025 | 38 | 0.280 |
Why?
|
| Body Size | 2 | 2019 | 6 | 0.270 |
Why?
|
| Adolescent | 4 | 2024 | 1881 | 0.270 |
Why?
|
| Dietary Supplements | 3 | 2022 | 53 | 0.270 |
Why?
|
| Lipid Metabolism | 2 | 2017 | 34 | 0.260 |
Why?
|
| Child | 3 | 2024 | 1157 | 0.260 |
Why?
|
| Prevalence | 3 | 2023 | 375 | 0.250 |
Why?
|
| Estrogen Receptor beta | 2 | 2016 | 4 | 0.250 |
Why?
|
| Amyloid beta-Peptides | 2 | 2024 | 198 | 0.240 |
Why?
|
| Sex Factors | 5 | 2020 | 387 | 0.240 |
Why?
|
| Epigenesis, Genetic | 4 | 2021 | 61 | 0.230 |
Why?
|
| Waist-Hip Ratio | 2 | 2015 | 12 | 0.230 |
Why?
|
| Coronary Artery Disease | 2 | 2017 | 124 | 0.230 |
Why?
|
| Coffee | 1 | 2024 | 3 | 0.220 |
Why?
|
| Vehicle Emissions | 1 | 2024 | 5 | 0.220 |
Why?
|
| Social Isolation | 1 | 2025 | 19 | 0.220 |
Why?
|
| Beverages | 1 | 2024 | 12 | 0.220 |
Why?
|
| Air Pollutants | 1 | 2024 | 11 | 0.220 |
Why?
|
| Particulate Matter | 1 | 2024 | 16 | 0.220 |
Why?
|
| Loneliness | 1 | 2025 | 42 | 0.220 |
Why?
|
| Dietary Fats | 1 | 2024 | 37 | 0.210 |
Why?
|
| Weight Gain | 3 | 2024 | 61 | 0.210 |
Why?
|
| Whole Grains | 1 | 2023 | 4 | 0.210 |
Why?
|
| Memory Disorders | 1 | 2024 | 108 | 0.210 |
Why?
|
| Florida | 1 | 2023 | 15 | 0.200 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2021 | 168 | 0.200 |
Why?
|
| Flavonols | 1 | 2022 | 5 | 0.190 |
Why?
|
| Time Factors | 7 | 2021 | 1262 | 0.190 |
Why?
|
| Anti-Mullerian Hormone | 1 | 2022 | 2 | 0.190 |
Why?
|
| Vitamin E | 1 | 2023 | 37 | 0.190 |
Why?
|
| Betacoronavirus | 2 | 2020 | 69 | 0.190 |
Why?
|
| Vitamins | 1 | 2022 | 14 | 0.190 |
Why?
|
| Comorbidity | 3 | 2022 | 426 | 0.190 |
Why?
|
| Smoking | 3 | 2020 | 161 | 0.180 |
Why?
|
| Gastrointestinal Diseases | 1 | 2022 | 26 | 0.180 |
Why?
|
| Lutein | 1 | 2021 | 3 | 0.180 |
Why?
|
| Zeaxanthins | 1 | 2021 | 3 | 0.180 |
Why?
|
| Carotenoids | 1 | 2021 | 14 | 0.180 |
Why?
|
| Survivors | 1 | 2022 | 69 | 0.180 |
Why?
|
| Diet Surveys | 1 | 2021 | 22 | 0.180 |
Why?
|
| Lipoproteins, HDL | 1 | 2021 | 23 | 0.180 |
Why?
|
| Leukocytes | 1 | 2021 | 30 | 0.180 |
Why?
|
| Health Status | 2 | 2019 | 200 | 0.170 |
Why?
|
| Neuropsychological Tests | 2 | 2021 | 865 | 0.170 |
Why?
|
| Nurses | 2 | 2018 | 41 | 0.170 |
Why?
|
| Diet, Western | 1 | 2021 | 6 | 0.170 |
Why?
|
| Amyloid | 1 | 2021 | 37 | 0.170 |
Why?
|
| Body Weight | 2 | 2018 | 129 | 0.170 |
Why?
|
| Weight Loss | 2 | 2020 | 121 | 0.170 |
Why?
|
| Eczema | 1 | 2020 | 3 | 0.170 |
Why?
|
| Lipase | 1 | 2020 | 4 | 0.160 |
Why?
|
| Phenotype | 2 | 2018 | 261 | 0.160 |
Why?
|
| Membrane Proteins | 1 | 2021 | 152 | 0.160 |
Why?
|
| Rhinitis, Allergic | 1 | 2020 | 14 | 0.160 |
Why?
|
| Geriatric Assessment | 1 | 2021 | 158 | 0.160 |
Why?
|
| Dyslipidemias | 2 | 2019 | 15 | 0.160 |
Why?
|
| Diabetes Mellitus | 2 | 2019 | 106 | 0.160 |
Why?
|
| Pancreas | 1 | 2020 | 30 | 0.160 |
Why?
|
| Neoplasms | 2 | 2020 | 216 | 0.160 |
Why?
|
| Food Hypersensitivity | 1 | 2020 | 40 | 0.160 |
Why?
|
| Autopsy | 1 | 2021 | 255 | 0.160 |
Why?
|
| Sex Hormone-Binding Globulin | 2 | 2018 | 16 | 0.160 |
Why?
|
| Inbreeding Depression | 1 | 2019 | 1 | 0.160 |
Why?
|
| Consanguinity | 1 | 2019 | 2 | 0.160 |
Why?
|
| Fertility | 1 | 2019 | 17 | 0.160 |
Why?
|
| Cholesterol, HDL | 2 | 2016 | 26 | 0.150 |
Why?
|
| Risk-Taking | 1 | 2019 | 28 | 0.150 |
Why?
|
| Socioeconomic Factors | 2 | 2019 | 256 | 0.150 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2019 | 30 | 0.150 |
Why?
|
| Ventricular Function, Left | 1 | 2019 | 34 | 0.150 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2018 | 4 | 0.150 |
Why?
|
| Antioxidants | 1 | 2018 | 56 | 0.140 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 439 | 0.140 |
Why?
|
| Insulin Resistance | 2 | 2017 | 48 | 0.140 |
Why?
|
| Androgens | 1 | 2018 | 7 | 0.140 |
Why?
|
| Lung Diseases | 1 | 2018 | 36 | 0.140 |
Why?
|
| Asthma | 1 | 2020 | 152 | 0.140 |
Why?
|
| Mother-Child Relations | 1 | 2018 | 27 | 0.140 |
Why?
|
| Endocrine Disruptors | 1 | 2018 | 1 | 0.140 |
Why?
|
| Child Behavior | 1 | 2018 | 28 | 0.140 |
Why?
|
| Basal Metabolism | 1 | 2018 | 7 | 0.140 |
Why?
|
| Fluorocarbons | 1 | 2018 | 11 | 0.140 |
Why?
|
| Testosterone | 1 | 2018 | 27 | 0.140 |
Why?
|
| Diet, Reducing | 1 | 2018 | 12 | 0.140 |
Why?
|
| Thiocyanates | 1 | 2017 | 4 | 0.140 |
Why?
|
| Hospitalization | 1 | 2020 | 286 | 0.140 |
Why?
|
| Perchlorates | 1 | 2017 | 5 | 0.140 |
Why?
|
| Nitrates | 1 | 2017 | 9 | 0.140 |
Why?
|
| Thyroid Function Tests | 1 | 2017 | 11 | 0.140 |
Why?
|
| Vascular Calcification | 1 | 2017 | 9 | 0.130 |
Why?
|
| Health Personnel | 1 | 2018 | 81 | 0.130 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2017 | 1 | 0.130 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2017 | 1 | 0.130 |
Why?
|
| Aspartate Aminotransferases | 1 | 2017 | 13 | 0.130 |
Why?
|
| Alanine Transaminase | 1 | 2017 | 15 | 0.130 |
Why?
|
| Protective Factors | 4 | 2018 | 20 | 0.130 |
Why?
|
| Cognition Disorders | 1 | 2022 | 692 | 0.130 |
Why?
|
| Fatty Liver | 1 | 2017 | 26 | 0.130 |
Why?
|
| Pregnancy | 1 | 2018 | 324 | 0.130 |
Why?
|
| Transportation | 1 | 2016 | 4 | 0.130 |
Why?
|
| Inhalation Exposure | 1 | 2016 | 5 | 0.130 |
Why?
|
| Histones | 1 | 2016 | 28 | 0.130 |
Why?
|
| Actigraphy | 1 | 2016 | 80 | 0.120 |
Why?
|
| Primary Prevention | 1 | 2016 | 22 | 0.120 |
Why?
|
| Case-Control Studies | 1 | 2017 | 481 | 0.120 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2016 | 5 | 0.120 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2016 | 9 | 0.120 |
Why?
|
| Cross-Sectional Studies | 4 | 2021 | 760 | 0.120 |
Why?
|
| Child, Preschool | 1 | 2018 | 567 | 0.120 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2016 | 7 | 0.120 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2016 | 6 | 0.120 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 42 | 0.120 |
Why?
|
| Waist-Height Ratio | 1 | 2015 | 5 | 0.120 |
Why?
|
| Adipose Tissue | 1 | 2016 | 73 | 0.120 |
Why?
|
| Cause of Death | 3 | 2022 | 54 | 0.110 |
Why?
|
| Health Behavior | 1 | 2016 | 137 | 0.110 |
Why?
|
| Sweating | 1 | 2014 | 2 | 0.110 |
Why?
|
| Hot Flashes | 1 | 2014 | 11 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 235 | 0.110 |
Why?
|
| Perimenopause | 1 | 2014 | 14 | 0.110 |
Why?
|
| Copper | 2 | 2024 | 14 | 0.100 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 442 | 0.100 |
Why?
|
| Risk | 3 | 2018 | 162 | 0.100 |
Why?
|
| Prognosis | 1 | 2015 | 730 | 0.100 |
Why?
|
| Multivariate Analysis | 3 | 2018 | 286 | 0.090 |
Why?
|
| Age Factors | 3 | 2022 | 638 | 0.090 |
Why?
|
| Triglycerides | 2 | 2025 | 54 | 0.090 |
Why?
|
| Cholesterol | 2 | 2025 | 57 | 0.090 |
Why?
|
| Genotype | 2 | 2024 | 248 | 0.080 |
Why?
|
| Quantitative Trait Loci | 2 | 2021 | 26 | 0.080 |
Why?
|
| Carnitine O-Palmitoyltransferase | 2 | 2021 | 2 | 0.080 |
Why?
|
| Educational Status | 2 | 2021 | 209 | 0.080 |
Why?
|
| Nutrition Surveys | 2 | 2018 | 21 | 0.070 |
Why?
|
| Walking | 2 | 2021 | 232 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2016 | 243 | 0.060 |
Why?
|
| Switzerland | 1 | 2024 | 8 | 0.060 |
Why?
|
| Nitrogen Dioxide | 1 | 2024 | 4 | 0.060 |
Why?
|
| Nitrogen Oxides | 1 | 2024 | 4 | 0.060 |
Why?
|
| Tea | 1 | 2024 | 4 | 0.060 |
Why?
|
| Bayes Theorem | 1 | 2024 | 32 | 0.060 |
Why?
|
| Food Handling | 1 | 2024 | 2 | 0.060 |
Why?
|
| Fast Foods | 1 | 2024 | 5 | 0.050 |
Why?
|
| Heterozygote | 1 | 2025 | 88 | 0.050 |
Why?
|
| Zinc | 1 | 2024 | 39 | 0.050 |
Why?
|
| Energy Intake | 1 | 2024 | 77 | 0.050 |
Why?
|
| Feeding Behavior | 1 | 2024 | 78 | 0.050 |
Why?
|
| Diet, Sodium-Restricted | 1 | 2023 | 7 | 0.050 |
Why?
|
| Caloric Restriction | 1 | 2023 | 11 | 0.050 |
Why?
|
| Hypertension | 1 | 2024 | 163 | 0.050 |
Why?
|
| Tocopherols | 1 | 2023 | 8 | 0.050 |
Why?
|
| alpha-Tocopherol | 1 | 2023 | 11 | 0.050 |
Why?
|
| Quercetin | 1 | 2022 | 5 | 0.050 |
Why?
|
| Kaempferols | 1 | 2022 | 6 | 0.050 |
Why?
|
| Diet, Vegetarian | 1 | 2022 | 5 | 0.050 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2022 | 22 | 0.050 |
Why?
|
| Brain Infarction | 1 | 2023 | 63 | 0.050 |
Why?
|
| Eating | 1 | 2022 | 46 | 0.050 |
Why?
|
| Memory, Short-Term | 1 | 2022 | 79 | 0.050 |
Why?
|
| Biological Specimen Banks | 1 | 2022 | 5 | 0.050 |
Why?
|
| United Kingdom | 1 | 2022 | 40 | 0.050 |
Why?
|
| Mental Status and Dementia Tests | 1 | 2022 | 42 | 0.050 |
Why?
|
| Vegetables | 1 | 2021 | 21 | 0.040 |
Why?
|
| Gene Expression | 1 | 2022 | 178 | 0.040 |
Why?
|
| Accelerometry | 1 | 2021 | 78 | 0.040 |
Why?
|
| Executive Function | 1 | 2021 | 89 | 0.040 |
Why?
|
| Music Therapy | 1 | 2020 | 2 | 0.040 |
Why?
|
| Intubation | 1 | 2020 | 5 | 0.040 |
Why?
|
| Meditation | 1 | 2020 | 21 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2020 | 17 | 0.040 |
Why?
|
| Homozygote | 1 | 2019 | 13 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 67 | 0.040 |
Why?
|
| Haplotypes | 1 | 2019 | 40 | 0.040 |
Why?
|
| Nursing Research | 1 | 2020 | 32 | 0.040 |
Why?
|
| Disease Management | 1 | 2020 | 100 | 0.040 |
Why?
|
| Diastole | 1 | 2019 | 28 | 0.040 |
Why?
|
| ADAMTS9 Protein | 1 | 2018 | 1 | 0.040 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2018 | 2 | 0.040 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 2018 | 2 | 0.040 |
Why?
|
| Lod Score | 1 | 2018 | 11 | 0.040 |
Why?
|
| Age of Onset | 1 | 2019 | 71 | 0.040 |
Why?
|
| Animals | 2 | 2016 | 3311 | 0.040 |
Why?
|
| Dehydroepiandrosterone | 1 | 2018 | 4 | 0.040 |
Why?
|
| Androstenedione | 1 | 2018 | 4 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2019 | 103 | 0.040 |
Why?
|
| Rest | 1 | 2018 | 28 | 0.030 |
Why?
|
| Symporters | 1 | 2017 | 5 | 0.030 |
Why?
|
| Life Tables | 1 | 2017 | 4 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2018 | 190 | 0.030 |
Why?
|
| Amino Acid Transport System ASC | 1 | 2017 | 1 | 0.030 |
Why?
|
| Amino Acid Transport System y+L | 1 | 2017 | 1 | 0.030 |
Why?
|
| Phosphoglycerate Dehydrogenase | 1 | 2017 | 1 | 0.030 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2017 | 3 | 0.030 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2017 | 5 | 0.030 |
Why?
|
| RNA Interference | 1 | 2017 | 36 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 801 | 0.030 |
Why?
|
| Transfection | 1 | 2017 | 117 | 0.030 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2017 | 1 | 0.030 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2017 | 2 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 52 | 0.030 |
Why?
|
| Histone Code | 1 | 2016 | 1 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2018 | 309 | 0.030 |
Why?
|
| ATP Binding Cassette Transporter 1 | 1 | 2016 | 2 | 0.030 |
Why?
|
| Bias | 1 | 2016 | 23 | 0.030 |
Why?
|
| Logistic Models | 1 | 2017 | 351 | 0.030 |
Why?
|
| Genome, Human | 1 | 2016 | 34 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2016 | 29 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 219 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 244 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 47 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2016 | 50 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 168 | 0.030 |
Why?
|
| Health | 1 | 2016 | 8 | 0.030 |
Why?
|
| Gardening | 1 | 2016 | 1 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2016 | 89 | 0.030 |
Why?
|
| Bicycling | 1 | 2016 | 3 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 128 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2016 | 132 | 0.030 |
Why?
|
| Arteries | 1 | 2016 | 13 | 0.030 |
Why?
|
| Sports | 1 | 2016 | 27 | 0.030 |
Why?
|
| Cardiology | 1 | 2016 | 45 | 0.030 |
Why?
|
| Cell Membrane Permeability | 1 | 2016 | 50 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2016 | 72 | 0.030 |
Why?
|
| Cell Movement | 1 | 2016 | 77 | 0.030 |
Why?
|
| Anxiety | 1 | 2016 | 143 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2016 | 163 | 0.030 |
Why?
|
| Depressive Disorder | 1 | 2016 | 163 | 0.030 |
Why?
|
| Inflammation | 1 | 2016 | 231 | 0.030 |
Why?
|
| Calcium | 1 | 2018 | 369 | 0.030 |
Why?
|
| Vasomotor System | 1 | 2014 | 3 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 577 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2016 | 398 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2020 | 2941 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2016 | 591 | 0.020 |
Why?
|